-
Harbour BioMed Appoints Yingying Chen, PhD, as Chief Financial Officer
prnasia
July 21, 2021
Harbour BioMed announced the appointment of Dr. Yingying Chen as Chief Financial Officer (CFO). Dr. Chen will be responsible for leading the overall management of Finance & Investor Relations and overseeing all aspects of financial operations.
-
AstraZeneca Appoints Aradhana Sarin As New Chief Financial Officer
americanpharmaceuticalreview
June 08, 2021
AstraZeneca PLC announced that the Board has appointed Aradhana Sarin as an Executive Director and Chief Financial Officer, conditional upon closing of AstraZeneca’s acquisition of Alexion Pharmaceuticals, Inc. (Closing) and effective on the later of ...
-
AffaMed Therapeutics Announces Appointment of Vijay Karwal as Chief Financial Officer
prnasia
May 17, 2021
AffaMed Therapeutics, a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, neurological and psychiatric disorders, today announced the appointment of Vijay Karwal as Chief Financial Officer.
-
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Financial Officer
prnasia
April 20, 2021
Himalaya Therapeutics today announced the appointment of Nicholas Desjardins as chief financial officer and corporate development officer.
-
Tessa Therapeutics Appoints David McIntyre as Chief Financial Officer
prnasia
December 18, 2020
Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced the appointment of David McIntyre as its Chief Financial Officer.
-
Frontida BioPharm Appoints Chief Financial Officer
contractpharma
December 03, 2020
Puneet Sapra brings 20 years of pharmaceutical and healthcare experience in executive roles at Pfizer, Johnson & Johnson, and Halma.
-
Byondis Announces Appointment of Chief Financial Officer
b3cnewswire
August 22, 2020
Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) is pleased to announce the appointment of Robbert Van Heekeren as chief financial officer.
-
Daxor Corporation Appoints Robert J. Michel as Chief Financial Officer
pharmafocusasia
September 29, 2018
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the appointment of Robert J. Mi